0000920465-20-000018.txt : 20200116 0000920465-20-000018.hdr.sgml : 20200116 20200116160522 ACCESSION NUMBER: 0000920465-20-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200114 FILED AS OF DATE: 20200116 DATE AS OF CHANGE: 20200116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wellinghoff Darryl CENTRAL INDEX KEY: 0001770350 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 20530974 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_157920870416334.xml FORM 4 X0306 4 2020-01-14 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001770350 Wellinghoff Darryl C/O LA JOLLA PHARMACEUTICAL COMPANY 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 0 1 0 0 Chief Commercial Officer Common Stock 2020-01-14 4 P 0 3000 8.2255 A 6545 D /s/ Ryan Murr, as attorney-in-fact for Darryl Wellinghoff 2020-01-16